These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20647769)

  • 1. Generation of antisera to purified prions in lipid rafts.
    Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
    Prion; 2010; 4(2):94-104. PubMed ID: 20647769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions.
    Stanker LH; Scotcher MC; Lin A; McGarvey J; Prusiner SB; Hnasko R
    Hybridoma (Larchmt); 2012 Oct; 31(5):314-24. PubMed ID: 23098297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Packaging of prions into exosomes is associated with a novel pathway of PrP processing.
    Vella LJ; Sharples RA; Lawson VA; Masters CL; Cappai R; Hill AF
    J Pathol; 2007 Apr; 211(5):582-590. PubMed ID: 17334982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological effects and use of PrPSc- and PrP-specific antibodies generated by immunization with purified full-length native mouse prions.
    Petsch B; Müller-Schiffmann A; Lehle A; Zirdum E; Prikulis I; Kuhn F; Raeber AJ; Ironside JW; Korth C; Stitz L
    J Virol; 2011 May; 85(9):4538-46. PubMed ID: 21345946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of soluble and insoluble PrP oligomers in the normal human brain.
    Xiao X; Yuan J; Zou WQ
    J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
    Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.
    Nakaoke R; Sakaguchi S; Atarashi R; Nishida N; Arima K; Shigematsu K; Katamine S
    Cell Mol Neurobiol; 2000 Dec; 20(6):717-30. PubMed ID: 11100979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.
    D'Castro L; Wenborn A; Gros N; Joiner S; Cronier S; Collinge J; Wadsworth JD
    PLoS One; 2010 Dec; 5(12):e15679. PubMed ID: 21187933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipid rafts in prion protein biology.
    Lewis V; Hooper NM
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
    Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
    J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation.
    Shoup D; Priola SA
    Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
    Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
    J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.